Canadian Institutes of Health Research

Canadian Psychedelic Trade Association Endorses Senate Report Calling for Research into Psychedelic-Assisted Therapy

Retrieved on: 
Wednesday, November 8, 2023
Psilocybin, Science, Government, Post-traumatic stress disorder, Parliament, Anxiety, MDMA, Veterans Affairs Canada, MDD, Chronic pain, Public, DND, Treatment, Health Canada, Veteran, Government of Canada, Doctor of Philosophy, Research, National security, Equitable Access to Care and Health Act, Canadian Institutes of Health Research, PTSD, OUD, CIHR, Atypical depression, DSM-IV codes, AUD, Partnership, VAC, TUD, House, Safety, Nicotine, Veterans' affairs, TRD, Mental health, Senate, Pharmaceutical industry, Nursing

OTTAWA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — enthusiastically endorses a new report by the Senate of Canada Subcommittee on Veteran Affairs urging federal, provincial, and territorial governments to launch and fund a large-scale research program into psychedelic-assisted therapy.

Key Points: 
  • OTTAWA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- PsyCan — the not-for-profit trade association of legally-operating Canadian psychedelic companies — enthusiastically endorses a new report by the Senate of Canada Subcommittee on Veteran Affairs urging federal, provincial, and territorial governments to launch and fund a large-scale research program into psychedelic-assisted therapy.
  • While Canada is a leader in developing these innovative treatments, many barriers remain to patient access, and government must play an active role.
  • “This report echoes our calls for government funding into psychedelic-assisted therapy,” said PharmAla Biotech CEO and PsyCan Chair Nick Kadysh.
  • “Research on these subjects is constantly evolving and will continue to do so.

GSK announces largest private financial contribution to CIHR's Team Grants initiative addressing threats to Canadian lung health

Retrieved on: 
Tuesday, September 26, 2023
Heart, GSK, British Thoracic Society, Canadian Thoracic Society, Atmosphere, Gas, Wildfire, Overalls, Water quality, International Workshop on Lung Health, COVID-19, Radon, Woman, Public, CIHR, Research, Brain, Inhalation, Lung cancer in Australia, History, Lung, Indigenous peoples, Death, Climate change, Patient, Risk, Canadian Institutes of Health Research, Viral, Health, Smoking, Air pollution, Virus, Herbal cigarette, Pharmaceutical industry, MISSISSAUGA

The funds will be managed and administered by the Canadian Institutes of Health Research (CIHR) through the Team Grants in Lung Health initiative.

Key Points: 
  • The funds will be managed and administered by the Canadian Institutes of Health Research (CIHR) through the Team Grants in Lung Health initiative.
  • GSK's contribution is the largest private financial contribution to this research initiative to date.
  • GSK is investing $2 million in research to address ongoing, new, and emerging threats to lung health in Canada.
  • Considering these and other significant threats to lung health, such as lung cancers, the effects of vaping on health, viral infections such as COVID-19, and the impacts of climate change, there is an urgent need for strategic investment in lung health research.1
    "The CIHR's Team Grants in Lung Health is the single largest investment in lung health research in the history of CIHR.

Brain Canada’s flagship program awards $2.8 million for brain research

Retrieved on: 
Thursday, September 21, 2023
Hospital for Sick Children, Hospital for Sick Children (Toronto), University, David Azrieli, Brain Research, Ambition Institute, Public, CIHR, Research, Directory, Azrieli Center, Disorder, LOI, Pain, Neuroscience, University of Toronto, Myenteric plexus, Canadian Institutes of Health Research, Brain, Government of Canada, Hospital, Health, Health Canada, Peer review, Injury, Medical device, Health insurance

MONTREAL, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Supported by the Canada Brain Research Fund and anchored by a lead gift from the Azrieli Foundation, the Future Leaders in Canadian Brain Research program aims to accelerate novel and transformative research that will fundamentally change our understanding of nervous system function and dysfunction and their impact on health. In its fourth year, this flagship program is providing funding to its largest-ever cohort of researchers, with 28 recipients—almost 30% more researchers than previous years. Over the course of four years, the Future Leaders in Canadian Brain Research program has granted awards to a total of 88 promising early-career researchers. The program is made possible through a substantial contribution from the Azrieli Foundation, with support this year from The Erika Legacy Foundation, The Arrell Family Foundation, the Segal Foundation, and the Canadian Institutes of Health Research (CIHR).

Key Points: 
  • Over the course of four years, the Future Leaders in Canadian Brain Research program has granted awards to a total of 88 promising early-career researchers.
  • With the support of Brain Canada and its donors and partners, these visionary researchers are making substantial contributions to brain research across the country and around the world.
  • “Brain Canada is the leading foundation dedicated to advancing neuroscience in this country,” says Naomi Azrieli, Brain Canada Chair.
  • To date, Health Canada has invested $200 million through the CBRF which has been matched by Brain Canada Foundation and its donors and partners.

Government of Canada invests in responsible artificial intelligence research at the Université de Montréal

Retrieved on: 
Friday, June 9, 2023
Natural science, The Honourable, Global Partnership on Artificial Intelligence, Social science, Development, Canadian Institute for Advanced Research, Advisory Council, Investment, Artificial intelligence, Federation, Chair, Brain, Research, SSHRC, Child, Canadian Institutes of Health Research, Drug discovery, Government of Canada, Engineering, Public, Government, Paradigm, Climate change, Humanities, Social Sciences and Humanities Research Council, Parliament, Partnership, Organization, Economy, University, Maternity leave and the Organisation for Economic Co-operation and Development, Intelligence, Minister of Innovation, Science and Industry, AIDA, AI, Ecosystem, Robotics, Health, Dairy, Medical device, Creative industries, Nursing, Tourism, Science

Canada was closely involved in the launch of the Global Partnership on Artificial Intelligence, through which the 29 member governments work collectively to orient AI technologies toward shared values.

Key Points: 
  • Canada was closely involved in the launch of the Global Partnership on Artificial Intelligence, through which the 29 member governments work collectively to orient AI technologies toward shared values.
  • Through the Canada First Research Excellence Fund, our government is proud to move even further ahead by investing $124 million into responsible artificial intelligence research.
  • – The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry
    "The Université de Montréal is home to ground-breaking research that is key to transforming the responsible adoption of artificial intelligence.
  • Created in 2014, the Canada First Research Excellence Fund (CFREF) supports Canadian post-secondary institutions in their efforts to become global research leaders.

Government of Canada invests in strategic research at Dalhousie University

Retrieved on: 
Friday, May 12, 2023
UQAR, Natural science, The Honourable, Social science, Child, Artificial intelligence, Federation, Chair, Refugee, Toronto Metropolitan University, University, Research, Brain, Concordia University, SSHRC, RNA therapeutics, Canadian Institutes of Health Research, TIPS, NS, McGill University, Government of Canada, Climate, DNA, Engineering, University of Calgary, York University, Public, Government, Parliament, Alumni, Paradigm, Climate change, Humanities, Social Sciences and Humanities Research Council, University of Toronto, Century, Partnership, Dalhousie, RNA, Laval, Dalhousie University, Robotics, Health, Creative industries, Renewable energy, Medical device, Bridge, Nursing, Science, Citizenship

To ensure Canada remains at the forefront of research, innovation and wealth generation, the Government of Canada is investing in the success of the country's researchers.

Key Points: 
  • To ensure Canada remains at the forefront of research, innovation and wealth generation, the Government of Canada is investing in the success of the country's researchers.
  • Today, Parliamentary Secretary Andy Fillmore and the Honourable Sean Fraser, Minister of Immigration, Refugees and Citizenship, highlighted an investment of more than $154 million in Dalhousie University through the Canada First Research Excellence Fund (CFREF).
  • – Ted Hewitt, Chair, Tri-agency Institutional Programs Secretariat Steering Committee; President, Social Sciences and Humanities Research Council of Canada; and Chair, Canada Research Coordinating Committee
    "I want to thank the federal government for this significant investment, the largest ever made in research at Dalhousie.
  • Created in 2014, the Canada First Research Excellence Fund (CFREF) supports Canadian post-secondary institutions in their efforts to become global research leaders.

Government of Canada invests $1.4 billion in strategic research at postsecondary institutions

Retrieved on: 
Friday, April 28, 2023
Toronto Metropolitan University, DNA, Partnership, Natural science, The Honourable, University of Calgary, University, Social science, York University, Public, Research, Brain, SSHRC, RNA, Natural Sciences and Engineering Research Council, Carbon, Social Sciences and Humanities Research Council, Government, Child, Paradigm, Humanities, Dalhousie University, RNA therapeutics, Canadian Institutes of Health Research, McGill University, Artificial intelligence, Century, Government of Canada, Robotics, Health, Chair, Creative industries, Renewable energy, Bridge, Nursing, Medical device, Science

To ensure Canada remains at the forefront of research, innovation and wealth generation, the Government of Canada is investing in the success of our researchers.

Key Points: 
  • To ensure Canada remains at the forefront of research, innovation and wealth generation, the Government of Canada is investing in the success of our researchers.
  • Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced an investment of $1.4 billion in support for 11 large-scale research initiatives in strategic areas, through the Canada First Research Excellence Fund (CFREF).
  • This investment will allow researchers at Canadian institutions to capitalize on the strengths of their respective research areas, and attract capital and world-class talent.
  • —Ted Hewitt, Chair, Tri-agency Institutional Programs Secretariat Steering Committee; President, Social Sciences and Humanities Research Council of Canada; and Chair, Canada Research Coordinating Committee
    Created in 2014, CFREF supports Canadian postsecondary institutions in their efforts to become global research leaders.

Government of Canada funds project to better understand the needs of Autistic adults in Canada

Retrieved on: 
Wednesday, April 19, 2023
Partnership, Employment, Framework, Canadian Academy of Health Sciences, The Honourable, Life, Spectrum, Policy, Quality of life, Public, Research, McMaster University, Loneliness, ASD, Outline of health sciences, Canadian Institutes of Health Research, PHAC, AAC, Knowledge, Ageing, Mental health, Caregiver, Legislation, Residential care, Nursing, Vaccine, Autism spectrum, Health

While there are supports available to autistic individuals and their families throughout their lives, traditionally, autism research to date has been largely focused on children and may not improve our understanding of the experiences and needs of Autistic adults.

Key Points: 
  • While there are supports available to autistic individuals and their families throughout their lives, traditionally, autism research to date has been largely focused on children and may not improve our understanding of the experiences and needs of Autistic adults.
  • The findings from this needs assessment survey will be used to inform the development of patient-reported outcome and experience measures specific to autism.
  • "Today, we are taking another step toward the national autism strategy and helping to address gaps in knowledge about the needs of Autistic adults in Canada.
  • Continued collaboration and knowledge-sharing across sectors and disciplines will help improve our understanding of autism, and support the needs of Autistic Canadians, their families and caregivers.

Canadian Cancer Society announces details of historic research funding program to transform low-survival cancers

Retrieved on: 
Friday, March 31, 2023
Survivor, Bureau of Oceans and International Environmental and Scientific Affairs, ICR, Cholangiocarcinoma, Canadian Cancer Society, Survival, Cancer, Quality of life, Lung cancer, Hope, Public, CIHR, Research, Brain, Risk, Doctor of Philosophy, American Cancer Society, Lung, Stomach, Death, Advisory Council, Patient, Canadian Institutes of Health Research, Esophageal cancer, Indigenous self-government in Canada, Artificial intelligence, Liver, CCS, Lotte, Health Canada, Caregiver, Disease, Medical imaging, Pharmaceutical industry, Birth control, Management, Vaccine, Partnership

In 2022 alone, an estimated 41% of all cancer deaths in Canada were due to one of these 6 cancers.

Key Points: 
  • In 2022 alone, an estimated 41% of all cancer deaths in Canada were due to one of these 6 cancers.
  • To transform outcomes for people with pancreatic, esophageal, brain, lung, liver and stomach cancers, more action-oriented research is urgently needed.
  • "Cancer Research Society is very proud to partner with CCS and Brain Canada to support highly transformational research that will impact clinical care for brain cancer patients," says Dajan O'Donnell, PhD, Director, Scientific Affairs and Partnerships.
  • "The Lotte & John Hecht Memorial Foundation prioritizes funding medical research that is novel, innovative and disruptive," says Alena Levitz, Executive Director.

CuePath Selected to Include Automated Compliance Monitoring with Centre Hospitalier de l'Université de Montréal

Retrieved on: 
Wednesday, March 22, 2023
Community nursing, Piaggio, Methamphetamine, Centre hospitalier, Clinical trial, Medicine, Public, Research, Pharmacy, Patient safety, Canadian Institutes of Health Research, Medical device

VANCOUVER, BC, March 22, 2023 /PRNewswire/ - CuePath Innovation, a provider of medication adherence solutions for the home healthcare market, announced today that it has been selected to provide its medication compliance monitoring system for a clinical trial led by the Centre Hospitalier de l'Université de Montréal Research Centre (CRCHUM).

Key Points: 
  • VANCOUVER, BC, March 22, 2023 /PRNewswire/ - CuePath Innovation, a provider of medication adherence solutions for the home healthcare market, announced today that it has been selected to provide its medication compliance monitoring system for a clinical trial led by the Centre Hospitalier de l'Université de Montréal Research Centre (CRCHUM).
  • This will be the first clinical trial in Canada to use Cuepath for automated medication compliance monitoring in the research protocol.
  • CuePath brings its automated medication compliance monitoring and analysis to the clinical trial, so researchers can accurately monitor and collect detailed data on medication intake, enhancing patient safety and allowing better evidence overall for treatment adherence.
  • CuePath CEO, Ken Piaggio, stated, "This will be the first clinical trial in Canada to use CuePath's automated medication adherence monitoring."

Andira Advances Lead Cannabinoid Compositions for Metastatic Breast Cancer through a Collaborative Research Agreement with Canada Research Chair in Oncology Dr. Karla Williams at the University of British Columbia

Retrieved on: 
Wednesday, March 22, 2023
Faculty, US Food Sovereignty Alliance, University, Pharmacy, Canada Research Chair, Programmed cell death protein 1, Andira, Cell proliferation, Cannabinoid, Woman, Public, CIHR, Research, Doctor of Philosophy, Assistant, Trial of the century, Blood, Pain, Breast, Selva, UBC Faculty of Medicine, Investigational New Drug, Canadian Institutes of Health Research, UBC, FDA, IND, Food, Breast cancer, Disease, Pharmaceutical industry, Birth control, Medical imaging

The endeavor aims to validate the pharmacologic effects of the lead compounds in the estrogen receptor positive (ER+) form of metastatic breast cancer.

Key Points: 
  • The endeavor aims to validate the pharmacologic effects of the lead compounds in the estrogen receptor positive (ER+) form of metastatic breast cancer.
  • "While treatments for many forms of breast cancer have improved considerably, that is not the case for metastatic breast cancer.
  • Dr. Karla Williams serves as the Canada Research Chair in Oncology at the Canadian Institutes of Health Research (CIHR).
  • Williams' research aims to improve breast cancer patient outcomes through the development of novel strategies to detect and treat breast cancer.